Abstract: Cyanobacteria produce a range of secondary metabolites, one being the neurotoxic non-protein amino acid β-N-methylamino-L-alanine (BMAA), proposed to be a causative agent of human neurodegeneration. As for most cyanotoxins, the function of BMAA in cyanobacteria is unknown. Here, we examined the effects of BMAA on the physiology of the filamentous nitrogen-fixing cyanobacterium Nostoc sp. PCC 7120. Our data show that exogenously applied BMAA rapidly inhibits nitrogenase activity (acetylene reduction assay), even at micromolar concentrations, and that the inhibition was considerably more severe than that induced by combined nitrogen sources and most other amino acids. BMAA also caused growth arrest and massive cellular glycogen accumulation, as observed by electron microscopy. With nitrogen fixation being a process highly sensitive to oxygen species we propose that the BMAA effects found here may be related to the production of reactive oxygen species, as reported for other organisms.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Berntzon, L.; Erasmie, S.; Celepli, N.; Eriksson, J.; Rasmussen, U.; Bergman, B. BMAA Inhibits Nitrogen Fixation in the Cyanobacterium Nostoc sp. PCC 7120. Mar. Drugs 2013, 11, 3091-3108.
Berntzon L, Erasmie S, Celepli N, Eriksson J, Rasmussen U, Bergman B. BMAA Inhibits Nitrogen Fixation in the Cyanobacterium Nostoc sp. PCC 7120. Marine Drugs. 2013; 11(8):3091-3108.
Berntzon, Lotta; Erasmie, Sven; Celepli, Narin; Eriksson, Johan; Rasmussen, Ulla; Bergman, Birgitta. 2013. "BMAA Inhibits Nitrogen Fixation in the Cyanobacterium Nostoc sp. PCC 7120." Mar. Drugs 11, no. 8: 3091-3108.